导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.09% | 1072/2951 |
| 近一周 | 0.03% | 1787/3207 |
| 近一月 | -0.03% | 1003/3213 |
| 近一季 | 0.49% | 542/3184 |
| 近半年 | 0.50% | 862/3102 |
| 近一年 | 1.46% | 919/2913 |
| 近两年 | 7.67% | 296/2411 |
| 近三年 | 12.09% | 337/2047 |
| 成立以来 | 83.25% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-0.28% 1655/3040 |
0.94% 1561/3451 |
-0.10% 1162/3498 |
- - |
| 2024 | 6.00% 438/3316 |
1.38% 884/3226 |
1.77% 270/3360 |
-0.05% 2703/3195 |
2.78% 349/3316 |
| 2023 | 4.11% 851/3108 |
1.10% 948/2776 |
1.26% 1102/2849 |
0.60% 1002/2940 |
1.10% 719/3108 |
| 2022 | 1.46% 1998/2726 |
0.49% 1142/1949 |
1.00% 929/2522 |
0.93% 1592/2598 |
-0.95% 2070/2732 |
| 2021 | 3.05% 1734/2409 |
-0.25% 1936/2068 |
0.78% 1663/2668 |
1.26% 904/2731 |
1.22% 754/2416 |
| 2020 | 2.57% 1024/2196 |
2.22% 523/1576 |
-0.40% 1153/2274 |
-0.17% 1337/2475 |
0.91% 1196/2563 |
| 2019 | 4.56% 471/1720 |
1.38% 741/1682 |
1.02% 199/1824 |
1.18% 753/1762 |
0.91% 1139/1956 |
| 2018 | 3.56% 814/1267 |
- - |
- - |
- - |
3.10% 79/1543 |
| 2017 | 1.81% 395/1017 |
- - |
- - |
- - |
- - |
| 2016 | 0.51% 266/769 |
- - |
- - |
- - |
- - |
| 2015 | 13.91% 47/377 |
- - |
- - |
- - |
- - |
| 2014 | 17.83% 39/251 |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 中欧纯债债券(LOF)C VS. () |